Close Menu

NEW YORK – Scandinavian private equity firm Summa Equity said Wednesday that it has acquired functional proteomics firm Sengenics.

Founded in 2008, Sengenics produces full-length folded protein arrays using its KREX protein folding technology. Currently, the company is focused on using the technology to discover autoantibody signatures that could be useful for detecting and managing autoimmune and infectious diseases and cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.